Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.85 | N/A |
PEG Ratio (TTM) | -0.31 | N/A |
P/S Ratio (TTM) | 0.81 | N/A |
P/B Ratio (TTM) | 0.62 | N/A |
P/FCF Ratio (TTM) | -5.96 | N/A |
Price to 5YR AVG Earnings Ratio | -0.13 | N/A |
Price to 5YR AVG FCF Ratio | -8.45 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -35.23% | N/A |
ROE (TTM) | -63.93% | N/A |
Net Profit Margin (TTM) | -85.56% | N/A |
ROIC 5YR AVG | -24.42% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -4.72% | -9.38% | -20.66% |
Revenue | -7.65% | -7.74% | -10.53% |
Net Income | -16.06% | -11.77% | -24.95% |
Cash Flow | -625.13% | -216.58% | -156.90% |
Health (30%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.79 | N/A |
Quick Ratio (TTM) | 0.26 | N/A |
D/E Ratio (TTM) | 0.61 | N/A |
Interest Coverage (TTM) | -26.21 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -2.74 | N/A |
Shares Outstanding Growth 5YR AVG | -3.17% | N/A |